IL28B polymorphisms predict the response to chronic hepatitis C virus infection treatment in a Mexican population. [electronic resource]
- Annals of hepatology
- 876-81 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1665-2681
Adult Age Factors Aged Antiviral Agents--therapeutic use Chi-Square Distribution Drug Therapy, Combination Female Gene Frequency Genotype Hepacivirus--genetics Hepatitis C, Chronic--diagnosis Humans Interferon-alpha--therapeutic use Interferons Interleukins--genetics Logistic Models Male Mexico--epidemiology Middle Aged Odds Ratio Phenotype Polyethylene Glycols--therapeutic use Polymorphism, Single Nucleotide Ribavirin--therapeutic use Risk Factors Treatment Outcome